EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Nanocarrier-Assisted Delivery of Drug(s) for the Targeted Treatment of Neurodegenerative Disease

Joseph S. D’Arrigo

International Journal of Translational Medicine · 19.08.2025 · 5 (3) · 37

DOI: 10.3390/ijtm5030037 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Translational Medicine, online erschienen am 19.08.2025. Verfasst von Joseph S. D’Arrigo. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Apolipoprotein A-I (apoA-I)-coated nanoemulsion particles target scavenger receptors. Adsorbed apoA-I (from the bloodstream) mediates/facilitates this targeted molecular contact, which is followed by receptor-mediated endocytosis and subsequent transcytosis of these same nanoemulsion (nanocarrier) particles across the blood–brain barrier (BBB). When the right drugs are added in advance to these high-density lipoprotein (HDL)-like nanocarriers, multifunctional combination treatment is achieved. This medication penetrates the BBB and targets particular cell-surface scavenger receptors, mainly class B type I (SR-BI). As a result, these (drug-carrying) nanoemulsions may find application in the biomedical therapy of complex medical disorders, such as dementia, as well as some aspects of aging. According to recent research, sustained inflammatory stimulation in the gut, such as via serum amyloid A (SAA), may cause the release of proinflammatory cytokines. Thus, using this “HDL-like” nanoemulsion vehicle to target drugs early (or even proactively) toward a major SAA receptor (like SR-BI), which is implicated in SAA-mediated cell-signaling processes that lead to aging and/or cognitive decline (and eventually Alzheimer’s disease or dementia), may be a useful preventive and therapeutic strategy.

Zitieren

APA

D’Arrigo, J. S. (2025). Nanocarrier-Assisted Delivery of Drug(s) for the Targeted Treatment of Neurodegenerative Disease. International Journal of Translational Medicine, 5(3), 37. https://doi.org/10.3390/ijtm5030037

Vancouver

D’Arrigo JS. Nanocarrier-Assisted Delivery of Drug(s) for the Targeted Treatment of Neurodegenerative Disease. International Journal of Translational Medicine. 2025;5(3):37. doi:10.3390/ijtm5030037

BibTeX
@article{DArrigo2025,
  author = {D’Arrigo, Joseph S.},
  title = {Nanocarrier-Assisted Delivery of Drug(s) for the Targeted Treatment of Neurodegenerative Disease},
  journal = {International Journal of Translational Medicine},
  year = {2025},
  volume = {5},
  number = {3},
  pages = {37},
  doi = {10.3390/ijtm5030037}
}
Kostenlos starten →